These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 37868967)

  • 1. Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma.
    Bao J; Betzler AC; Hess J; Brunner C
    Front Immunol; 2023; 14():1233085. PubMed ID: 37868967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma.
    Liu Z; Meng X; Tang X; Zou W; He Y
    Cancer Immunol Immunother; 2023 Jun; 72(6):1505-1521. PubMed ID: 36481914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine-producing regulatory B cells in head and neck cancer.
    Jeske SS; Brand M; Ziebart A; Laban S; Doescher J; Greve J; Jackson EK; Hoffmann TK; Brunner C; Schuler PJ
    Cancer Immunol Immunother; 2020 Jul; 69(7):1205-1216. PubMed ID: 32146518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tertiary Lymphoid Structure Raises Survival and Immunotherapy in HPV
    Li H; Zhu SW; Zhou JJ; Chen DR; Liu J; Wu ZZ; Wang WY; Zhang MJ; Sun ZJ
    J Dent Res; 2023 Jun; 102(6):678-688. PubMed ID: 36883630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and Differentiation of the Tumor Microenvironment (TME) of Orthotopic and Subcutaneously Grown Head and Neck Squamous Cell Carcinoma (HNSCC) in Immunocompetent Mice.
    Brand M; Laban S; Theodoraki MN; Doescher J; Hoffmann TK; Schuler PJ; Brunner C
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma.
    Ruffin AT; Cillo AR; Tabib T; Liu A; Onkar S; Kunning SR; Lampenfeld C; Atiya HI; Abecassis I; Kürten CHL; Qi Z; Soose R; Duvvuri U; Kim S; Oesterrich S; Lafyatis R; Coffman LG; Ferris RL; Vignali DAA; Bruno TC
    Nat Commun; 2021 Jun; 12(1):3349. PubMed ID: 34099645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tertiary lymphoid structures in head and neck squamous cell carcinoma improve prognosis by recruiting CD8
    Wang M; Zhai R; Wang M; Zhu W; Zhang J; Yu M; Zhang W; Ye J; Liu L
    Mol Oncol; 2023 Aug; 17(8):1514-1530. PubMed ID: 36825382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.
    Zhang J; Zhong X; Jiang H; Jiang H; Xie T; Tian Y; Li R; Wang B; Zhang J; Yuan Y
    Aging (Albany NY); 2020 Nov; 12(22):22509-22526. PubMed ID: 33216727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial dynamics of tertiary lymphoid aggregates in head and neck cancer: insights into immunotherapy response.
    Sadeghirad H; Monkman J; Tan CW; Liu N; Yunis J; Donovan ML; Moradi A; Jhaveri N; Perry C; Adams MN; O'Byrne K; Warkiani ME; Ladwa R; Hughes BGM; Kulasinghe A
    J Transl Med; 2024 Jul; 22(1):677. PubMed ID: 39049036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of tumor-infiltrating lymphocytes from head and neck squamous cell carcinoma to assess the potential of adoptive cell therapy.
    Choi S; Hossain M; Lee H; Baek J; Park HS; Lim CL; Han D; Park T; Kim JH; Gong G; Kweon MN; Lee HJ
    Cancer Immunol Immunother; 2024 Apr; 73(6):101. PubMed ID: 38630265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor immune microenvironment in head and neck cancers.
    Chen SMY; Krinsky AL; Woolaver RA; Wang X; Chen Z; Wang JH
    Mol Carcinog; 2020 Jul; 59(7):766-774. PubMed ID: 32017286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXC ligand 13 orchestrates an immunoactive microenvironment and enhances immunotherapy response in head and neck squamous cell carcinoma.
    Lin X; Zhao X; Chen Y; Yang R; Dai Z; Li W; Lin C; Cao W
    Int J Immunopathol Pharmacol; 2024; 38():3946320241227312. PubMed ID: 38252495
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma.
    Deguchi S; Tanaka H; Suzuki S; Natsuki S; Mori T; Miki Y; Yoshii M; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
    BMC Cancer; 2022 Jun; 22(1):699. PubMed ID: 35751038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of immune response biomarkers (PD‑L1, p16, CD3+ and CD8+ TILs) in recurrent head and neck squamous cell carcinoma within previously irradiated areas.
    Pflumio C; Thomas J; Salleron J; Faivre JC; Borel C; Dolivet G; Sastre-Garau X; Geoffrois L
    Oncol Rep; 2021 Mar; 45(3):1273-1283. PubMed ID: 33432367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.
    Hirata-Nozaki Y; Ohkuri T; Ohara K; Kumai T; Nagata M; Harabuchi S; Kosaka A; Nagato T; Ishibashi K; Oikawa K; Aoki N; Ohara M; Harabuchi Y; Uno Y; Takei H; Celis E; Kobayashi H
    J Transl Med; 2019 Jun; 17(1):207. PubMed ID: 31221178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B Cell Orchestration of Anti-tumor Immune Responses: A Matter of Cell Localization and Communication.
    Kinker GS; Vitiello GAF; Ferreira WAS; Chaves AS; Cordeiro de Lima VC; Medina TDS
    Front Cell Dev Biol; 2021; 9():678127. PubMed ID: 34164398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicle-like tertiary lymphoid structures: A potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma.
    Liang H; Zhang Z; Guan Z; Zheng S; Lou J; Liu W; Cai Q; Si Y
    Front Immunol; 2023; 14():1096220. PubMed ID: 36776859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cancer: Emerging field of regulatory B-cell-targeted immunotherapies.
    Senturk ZN; Akdag I; Deniz B; Sayi-Yazgan A
    Front Immunol; 2023; 14():1152551. PubMed ID: 37033931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [B cells in head and neck oncology].
    Schuler PJ; Brunner C; Hoffmann TK
    HNO; 2018 Apr; 66(4):296-300. PubMed ID: 29500500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma.
    Mito I; Takahashi H; Kawabata-Iwakawa R; Ida S; Tada H; Chikamatsu K
    Sci Rep; 2021 Aug; 11(1):16134. PubMed ID: 34373557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.